News
Wandercraft’s Exoskeleton Gets FDA OK for Wider Use in Rehab
The U.S. Food and Drug Administration has granted Wandercraft expanded clearance to use its Atalante X robotic exoskeleton with individuals who have spinal cord injuries from levels C4 to L5 and those with multiple sclerosis.